Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Ovarian Cancer
Interventions
DRUG

Paclitaxel

175 mg/m2, I.V, every 2 weeks

DRUG

Carboplatin

Carboplatin AUC, I.V, 5 every 2 weeks

Trial Locations (12)

71110

University Hospital of Crete, Heraklion

Unknown

University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli

"IASO General Hospital of Athnes, Dep of Medical Oncology", Athens

"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens

"Department of Medical Oncology, Marika Iliadis Hospital of Athens", Athens

Department of Medical Oncology, Air Forces Military Hospital of Athens, Athens

Medical Oncology Unit, 401 Military Hospital of Athens, Athens

State General Hospital of Larissa, Dep of Medical Oncology, Larissa

"First Department of Medical Oncology, Metaxa's Anticancer Hospital of Pireas", Piraeus

"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki

Interbalkan Hospital, division of Oncology, Pylaia, Thessaloniki, Thessaloniki

"Medical Oncology Unit, AXEPA General Hospital of Thessaloniki", Thessaloniki

All Listed Sponsors
collaborator

University Hospital of Crete

OTHER

lead

Hellenic Oncology Research Group

OTHER